“The compound SR-17018 is the primary biased agonist on the mu opioid receptor that does not result in tolerance with chronic use,” claims Stahl, a senior personnel scientist inside the Bohn lab. “This can be a desirable feature for opportunity use while in the context of Persistent, severe agony.” https://zanetdksy.wikidank.com/1518721/an_unbiased_view_of_sr_17018_purchase